Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.68 USD | -0.09% | -0.51% | -24.06% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.06% | 8.32B | |
+2.54% | 108B | |
+9.78% | 105B | |
+0.15% | 23.46B | |
-12.49% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.47% | 17.19B | |
+6.12% | 13.99B | |
+35.22% | 12.53B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Scotiabank Upgrades Legend Biotech to Sector Outperform From Sector Perform, Price Target is $65